5% stakes
Blue Owl Capital Holdings
Institution
- 5% stake reports
- 23
- 5% stake stocks
- 11
- Latest report
- 26/08/12
5% stake reports
| Stock | ||
|---|---|---|
| Context Therapeutics CNTX08/12 | 3.19%2,934,015 sh | −2.4pp |
| Aktis Oncology AKTS05/14 | 5.92%3,161,348 sh | First report |
| Context Therapeutics CNTX05/14 | 5.54%5,089,015 sh | −2.9pp |
| ImageneBio IMA05/14 | 8.51%959,337 sh | +1.1pp |
| Finance of America Companies FOA02/12 | 9.49%827,409 sh | First report |
| FS Credit Opportunities FSCO02/12 | 0%0 sh | −16.7pp |
| Nuveen Churchill Direct Lending NCDL02/12 | 4.34%2,143,626 sh | −1.9pp |
| ImageneBio IMA02/12 | 7.37%823,785 sh | +2.5pp |
| Biomea Fusion BMEA02/12 | 5.92%4,451,219 sh | +2.5pp |
| Biomea Fusion BMEA25/11/14 | 3.42%2,500,000 sh | −2.7pp |
| Katapult Holdings KPLT25/11/05 | 0.47%21,421 sh | −48.1pp |
| Katapult Holdings KPLT25/10/29 | 48.55%4,306,771 sh | +2.1pp |
| Katapult Holdings KPLT25/10/23 | 46.41%3,952,776 sh | +3.7pp |
| Katapult Holdings KPLT25/10/20 | 42.74%3,407,261 sh | +4.2pp |
| Katapult Holdings KPLT25/10/14 | 38.58%2,867,316 sh | +2.3pp |
| Katapult Holdings KPLT25/10/06 | 36.32%2,603,447 sh | +23.6pp |
| Katapult Holdings KPLT25/09/05 | 12.76%667,685 sh | First report |
| Biomea Fusion BMEA25/08/11 | 6.13%3,800,000 sh | First report |
| Marker Therapeutics MRKR25/05/15 | 9.99%1,127,052 sh | +4.8pp |
| Marker Therapeutics MRKR25/02/14 | 5.18%554,250 sh | First report |
